Financials Y.S.P. Southeast Asia Holding

Equities

YSPSAH

MYL7178OO006

Pharmaceuticals

End-of-day quote BURSA MALAYSIA 06:00:00 2024-05-02 pm EDT 5-day change 1st Jan Change
2.48 MYR 0.00% Intraday chart for Y.S.P. Southeast Asia Holding +0.40% +7.83%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 380.3 325.2 320.9 271.9 359.6 326.2
Enterprise Value (EV) 1 341.7 279.5 285.3 191.8 256.5 248.3
P/E ratio 12.6 x 14.1 x 14.6 x 17.9 x 10.4 x 8.73 x
Yield 2.55% 3% 3.07% 3.63% 2.94% 3.48%
Capitalization / Revenue 1.32 x 1.1 x 1.08 x 0.96 x 1.08 x 0.92 x
EV / Revenue 1.18 x 0.95 x 0.96 x 0.68 x 0.77 x 0.7 x
EV / EBITDA 6.35 x 6.29 x 6.56 x 5.28 x 4.32 x 3.8 x
EV / FCF -22.8 x 11.2 x -49.4 x 3.26 x 7.69 x -25.9 x
FCF Yield -4.38% 8.91% -2.02% 30.7% 13% -3.86%
Price to Book 1.21 x 0.99 x 0.94 x 0.78 x 0.97 x 0.83 x
Nbr of stocks (in thousands) 138,302 139,584 140,760 140,900 141,035 141,845
Reference price 2 2.750 2.330 2.280 1.930 2.550 2.300
Announcement Date 4/29/19 5/29/20 4/27/21 4/22/22 4/25/23 4/23/24
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 288.8 295.6 297.1 281.9 334.2 355
EBITDA 1 53.83 44.46 43.49 36.3 59.33 65.34
EBIT 1 43.29 33.21 31.85 23.84 47.85 54.14
Operating Margin 14.99% 11.23% 10.72% 8.46% 14.32% 15.25%
Earnings before Tax (EBT) 1 42.3 31.83 30.26 22.49 47.69 53.82
Net income 1 30.35 23.01 21.98 15.18 34.47 37.32
Net margin 10.51% 7.78% 7.4% 5.39% 10.31% 10.51%
EPS 2 0.2186 0.1650 0.1561 0.1076 0.2441 0.2636
Free Cash Flow 1 -14.97 24.9 -5.773 58.93 33.35 -9.574
FCF margin -5.19% 8.42% -1.94% 20.91% 9.98% -2.7%
FCF Conversion (EBITDA) - 56.01% - 162.35% 56.2% -
FCF Conversion (Net income) - 108.22% - 388.15% 96.75% -
Dividend per Share 2 0.0700 0.0700 0.0700 0.0700 0.0750 0.0800
Announcement Date 4/29/19 5/29/20 4/27/21 4/22/22 4/25/23 4/23/24
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 38.7 45.7 35.6 80.1 103 78
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -15 24.9 -5.77 58.9 33.3 -9.57
ROE (net income / shareholders' equity) 9.77% 6.87% 6.5% 4.31% 9.53% 9.71%
ROA (Net income/ Total Assets) 6.92% 4.92% 4.52% 3.32% 6.49% 6.8%
Assets 1 438.8 468 486 456.8 531.2 548.5
Book Value Per Share 2 2.280 2.350 2.430 2.460 2.640 2.790
Cash Flow per Share 2 0.5500 0.6500 0.6200 0.8500 0.9200 0.9200
Capex 1 28.9 3.9 10 3.42 4.25 35.6
Capex / Sales 9.99% 1.32% 3.37% 1.21% 1.27% 10.04%
Announcement Date 4/29/19 5/29/20 4/27/21 4/22/22 4/25/23 4/23/24
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. YSPSAH Stock
  4. Financials Y.S.P. Southeast Asia Holding
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW